ArticleJournal of thoracic disease2018

Pan-endoscopic tumor length as the marker to predict response to neoadjuvant therapy for ESCC warrants additional investigation.

Yu-Feng Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.